Wird geladen...
Identification of CD318 (CDCP1) as novel prognostic marker in AML
Genetic and morphological markers are well-established prognostic factors in acute myeloid leukemia (AML). However, further reliable markers are urgently needed to improve risk stratification in AML. CD318 (CDCP1) is a transmembrane protein which in solid tumors promotes formation of metastasis and...
Gespeichert in:
| Veröffentlicht in: | Ann Hematol |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer Berlin Heidelberg
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7060168/ https://ncbi.nlm.nih.gov/pubmed/31965270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-020-03907-9 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|